Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.

Browse

Order by:     Display #  

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>


Novacea Inc: Premium Company Profile

Novacea is a development stage biopharmaceutical company engaged in in-licensing, developing and commercializing of novel therapies for the treatment of diseases in the therapeutic area of oncology. The company’s lead candidate, Ascenter, is a Ph


$495.00     Product Details...


Affymax Inc: Premium Company Profile

High impact company profile available at BioMarket


$495.00    Product Details...


Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile
Analysis of Chugai’s corporate strategy, marketed portfolio, pipeline potential and financial position in 2007 and to 2013

$5 700.00    Product Details...


Axcan Pharma Inc: Premium Company Profile

High impact company profile available at BioMarket


$495.00    Product Details...


Jazz Pharmaceuticals Inc: Premium Company Profile

Jazz Pharmaceuticals Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile


$495.00    Product Details...


C.R. Bard Inc: Premium Company Profile

C.R. Bard (Bard), which celebrated its centenary in 2007, is one of the leading global developer, manufacturer and marketer of medical technologies in the fields of vascular, urology, oncology and surgical specialty products. The company has pioneered


$495.00     Product Details...


ISIS Pharmaceuticals Inc: Premium Company Profile

High impact company profile available at BioMarket


$495.00    Product Details...


ADVENTRX Pharmaceuticals Inc: Premium Company Profile

ADVENTRX Pharmaceuticals Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile


$495.00    Product Details...


GTC Biotherapeutics Inc: Premium Company Profile

High impact company profile available at BioMarket


$495.00    Product Details...


Protherics PLC: Premium Company Profile

Protherics PLC: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile


$495.00    Product Details...


Incyte Corporation: Premium Company Profile

Incyte is a development stage company involved in drug discovery and development activities with major focus on developing small molecule drugs to treat various diseases. The company has proprietary product pipeline in various stages of development for


$495.00    Product Details...


Tercica Inc: Premium Company Profile

High impact company profile available at BioMarket


$495.00    Product Details...


BioMimetic Therapeutics Inc: Premium Company Profile

BioMimetic Therapeutics Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile


$495.00    Product Details...


QLT Inc: Premium Company Profile

High impact company profile available at BioMarket


$495.00    Product Details...


Titan Pharmaceuticals Inc: Premium Company Profile

Titan Pharmaceuticals Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile


$495.00    Product Details...


Medicis Pharmaceutical Corporation: Premium Company Profile

High impact company profile available at BioMarket


$495.00    Product Details...


Dendreon Corporation: Premium Company Profile

Dendreon Corporation: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile


$495.00    Product Details...


Becton, Dickinson and Co: Premium Company Profile

Becton, Dickinson and Company (BD), a medical technology company, improves drug therapy, enhances the diagnosis of infectious diseases and advances drug discovery. It manufactures and sells a broad range of medical supplies, devices, laboratory equipme


$495.00    Product Details...


Antisoma plc: Premium Company Profile

Antisoma is a development stage biotechnology company focused on the development of novel anticancer drugs. The Company has built a diversified product pipeline based on in-licensing and acquisitions that target a variety of tumors by different mechani


$495.00    Product Details...


Varian Medical Systems Inc: Premium Company Profile

Varian Medical Systems (Varian) is one of the leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company is also a supplier of tub


$495.00    Product Details...


Halozyme Therapeutics Inc: Premium Company Profile

Halozyme Therapeutics Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile


$495.00    Product Details...


Cytori Therapeutics Inc: Premium Company Profile

Cytori Therapeutics (previously MacroPore Biosurgery), based in San Diego, California, is one of the leading companies in the development and commercialization of regenerative medicine products.


$495.00    Product Details...


Exelixis Inc: Premium Company Profile

High impact company profile available at BioMarket


$495.00    Product Details...


Renovis: Premium Company Profile

High impact company profile available at BioMarket


$495.00    Product Details...


Transition Therapeutics Inc: Premium Company Profile

Transition Therapeutics is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. The company’s patented drug discovery technologies have helped the company in expanding its pipeline portfolio.


$495.00     Product Details...


Seattle Genetics, Inc:Premium Company Profile

High impact company profile available at BioMarket


$495.00    Product Details...


Eli Lilly & Co.: PharmaVitae Profile 2008
Analysis of Eli Lilly’s corporate strategy, marketed portfolio, pipeline potential and financial position in 2007 and to 2013

$5 700.00    Product Details...


Omrix Biopharmaceuticals Inc: Premium Company Profile

High impact company profile available at BioMarket


$495.00    Product Details...


Natus Medical Inc: Premium Company Profile

Natus Medical Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile


$495.00    Product Details...


Lexicon Pharmaceuticals Inc: Premium Company Profile

Lexicon Pharmaceuticals is a biopharmaceutical company focused on clinical development in the areas of irritable bowel syndrome, cognitive disorders, autoimmune diseases, and carcinoid syndrome. The company uses its proprietary gene knockout technology


$495.00    Product Details...


<< Start < Prev 1 2 3 4 5 6